Filtered By:
Condition: Heart Attack
Management: American Medical Association (AMA)
This page shows you your search results in order of date.
Order by Relevance | Date
Total 25 results found since Jan 2013.
Treat-to-Target or High-Intensity Statin in Patients With Coronary Artery Disease
This randomized clinical trial compares the efficacy of a treat-to-target low-density lipoprotein cholesterol (LDL-C) strategy of 50 to 70 mg/dL as the goal vs high-intensity statin therapy for the 3-year composite of death, myocardial infarction, stroke, or coronary revascularization in patients with coronary artery disease.
Source: JAMA - Journal of the American Medical Association - March 6, 2023 Category: General Medicine Source Type: research
Acute Myocardial Infarction and Ischemic Stroke After COVID-19 by Vaccination Status
This retrospective cohort study examines the incidence of acute myocardial infarction and ischemic stroke after COVID-19 infection among vaccinated vs unvaccinated adults in Korea.
Source: JAMA - Journal of the American Medical Association - July 22, 2022 Category: General Medicine Source Type: research
Myocardial Infarction, Stroke, and Pulmonary Embolism After BNT162b2 mRNA COVID-19 Vaccine
This population based study evaluated the short-term risk of severe cardiovascular risks among French residents 75 years or older after they received the BNT162b2 mRNA vaccination.
Source: JAMA - Journal of the American Medical Association - November 22, 2021 Category: General Medicine Source Type: research
Changes in Patterns of Acute MI or Ischemic Stroke Hospitalization During COVID-19 Surges
This study evaluates changes in rates of patients hospitalized for acute myocardial infarction (AMI) or suspected stroke during COVID-19 surges in the US as a measure of willingness to seek care during the pandemic.
Source: JAMA - Journal of the American Medical Association - June 2, 2021 Category: General Medicine Source Type: research
National Initiatives to Prevent Myocardial Infarction and Stroke
This Viewpoint discusses the Million Hearts initiative, a national effort that aims to prevent a million myocardial infarctions and strokes over 5 years, and proposes actions and strategies federal agencies can take to advance tobacco control, sodium reduction, trans fat elimination, hypertension control, and centering the US health care system on primary care.
Source: JAMA - Journal of the American Medical Association - March 12, 2021 Category: General Medicine Source Type: research
Diagnosis, Management, and Pathophysiology of Arterial and Venous Thrombosis in COVID-19
This JAMA Insights review summarizes the pathophysiology underlying the thrombotic diathesis characteristic of acute SARS-CoV-2 infection and current recommendations for the prevention, diagnosis, and management of the most common thrombotic complications in COVID-19, including acute myocardial infarction (AMI), ischemic stroke, and venous thromboembolism (VTE).
Source: JAMA - Journal of the American Medical Association - November 23, 2020 Category: General Medicine Source Type: research
Study: Fish Oil Doesn ’ t Seem To Prevent Heart Problems
This study is consistent with earlier trials.
The US Food and Drug Administration approved the fish oil-based drug Vascepa for heart attack and stroke prevention in 2019.
Nissen hopes the FDA will take a look at these studies and reconsider that decision.
“But it’s hard to get something undone once the genie gets out of the bottle,” he said.
An editorial in the journal that accompanies the study written by Dr. Gregory Curfman, assistant professor of medicine at Harvard Medical School, also suggested the FDA should require a postmarketing clinical trial of a high-dose of fish oil, such as Vascepa, vs. corn...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - November 16, 2020 Category: Consumer Health News Authors: CBS Boston Tags: Boston News Health Syndicated CBSN Boston CNN fish oil Source Type: news
Role of Bariatric Surgery in Managing Macrovascular Complications of Obesity-Related Type 2 Diabetes
Reducing the risk of macrovascular events, including myocardial infarction and stroke, is a major goal when treating diabetes. Despite this focus, of the major randomized trials used to support current diabetes guidelines (ACCORD, ADVANCE, UKPDS 33, UKPDS 34, VADT), none showed reductions in macrovascular events when the trial results were first reported. For example, UKPDS is still frequently cited in support of aggressive glucose lowering, yet when the primary outcome data were presented in 1998, the results showed no difference between groups in terms of reducing the risk of all-cause mortality (relative risk [RR], 0.94...
Source: JAMA - Journal of the American Medical Association - September 2, 2019 Category: General Medicine Source Type: research
Catheter Ablation for Atrial Fibrillation
Atrial fibrillation (AF) is the most common heart rhythm disturbance, with an estimated 33.5 million people affected worldwide. By age 75 years, more than 10% of the population will have developed AF. It is well recognized that AF increases the risk of thromboembolic stroke; however, AF also increases the risk of other highly morbid conditions such as heart failure (HF). As a result, even in the modern era of anticoagulation, mortality rates among patients with AF remain up to 2-fold higher than mortality rates among individuals without AF. For many patients, AF also has a major detrimental effect on quality of life, simil...
Source: JAMA - Journal of the American Medical Association - March 15, 2019 Category: General Medicine Source Type: research
Should you take statins? Guidelines offer different answers
When it comes to using statins to prevent a first heart attack or stroke, one leading US guideline recommends the drugs to 9 million more people than the other, according to a study published in the Journal of the American Medical Association.
Source: CNN.com - Health - January 1, 2018 Category: Consumer Health News Source Type: news
3 Major Health Problems That Disproportionately Affect Vets
Veterans are more likely to report very good or excellent health than their civilian counterparts, so they may not realize that they’re also at greater risk than civilians for some long-term health problems.
Of course, many veterans have acute physical health problems, like wounds and amputations, and trauma-based mental health issues like depression and PTSD. Indeed, mental health issues affect 30 percent of Vietnam veterans, 20 percent of Iraqi veterans and about 10 percent of Gulf War and Afghanistan veterans.
Less known are some of the ordinary, chronic conditions that disproportionately affect ser...
Source: Science - The Huffington Post - November 11, 2016 Category: Science Source Type: news
Plant-Based Diets Protect From Heart Disease Better Than Mediterranean Diets
The Mediterranean diet has long been touted for its benefits as an overall balanced way of eating. A study published in the New England Journal of Medicine looked at the Mediterranean diet as it relates to prevention of heart disease, finding that it may be protective against heart attack and stroke.
But according to Washington DC based group, the Physicians Committee for Responsible Medicine, a better way to prevent heart disease is to focus on high-fiber, plant-based foods. These include fruits, vegetables, legumes and whole grains. These foods provide safe and healthy sources of omega-3 fats without the risks of toxin...
Source: Healthy Living - The Huffington Post - August 10, 2016 Category: Consumer Health News Source Type: news
To Your Health: NLM update: Salt linked to heart disease among CKD patients
Listen to the To Your Health: NLM update on Salt linked to heart disease among CKD patients. The transcript is also available.
Adults who have chronic kidney disease - and eat a diet high in salt - comparatively increase their odds of a heart attack or stroke, finds a pioneering study recently published in the Journal of the American Medical Association..
Source: What's New on MedlinePlus - July 28, 2016 Category: Consumer Health News Source Type: news
SPRINT Results in Older Patients
In this issue of JAMA, Williamson and colleagues report the results of a preplanned, appropriately powered subgroup analysis of data from the Systolic Blood Pressure intervention Trial (SPRINT) in persons aged 75 years or older. SPRINT was a randomized, clinical, open-label study of community-dwelling older adults with systolic blood pressure (SBP) in the 130 to 180 mm Hg range in whom the effects of reducing SBP to less than 120 mm Hg (intensive treatment group) were compared with those associated with SBP lowering to less than 140 mm Hg (standard treatment group). The primary end point was a composite of cardiovascular d...
Source: JAMA - Journal of the American Medical Association - May 19, 2016 Category: Journals (General) Source Type: research
